Invuity Inc. (NASDAQ:IVTY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage currently has a $15.00 price objective on the stock. Zacks Investment Research’s target price points to a potential upside of 9.17% from the stock’s current price.

According to Zacks, “Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California. “

A number of other analysts have also recently commented on the stock. Leerink Swann restated a “buy” rating and issued a $15.00 price objective on shares of Invuity in a research report on Thursday, June 23rd. TheStreet cut shares of Invuity to a “sell” rating in a research report on Tuesday, July 19th. Craig Hallum initiated coverage on shares of Invuity in a research report on Monday, August 29th. They issued a “buy” rating and a $25.00 price objective for the company. Piper Jaffray Cos. restated an “overweight” rating and issued a $12.00 price objective on shares of Invuity in a research report on Wednesday, July 20th. Finally, Lake Street Capital initiated coverage on shares of Invuity in a research report on Monday. They issued a “buy” rating and a $18.00 price objective for the company. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $17.00.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/invuity-inc-ivty-upgraded-by-zacks-investment-research-to-buy.html

Shares of Invuity (NASDAQ:IVTY) traded up 0.37% during mid-day trading on Tuesday, hitting $13.74. The company’s stock had a trading volume of 207,011 shares. The stock’s market cap is $184.75 million. The company has a 50-day moving average price of $12.24 and a 200-day moving average price of $8.89. Invuity has a 1-year low of $4.80 and a 1-year high of $15.46.

Invuity (NASDAQ:IVTY) last posted its quarterly earnings results on Tuesday, July 19th. The company reported ($0.76) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.81) by $0.05. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $8.04 million. Invuity had a negative return on equity of 113.16% and a negative net margin of 156.54%. Analysts predict that Invuity will post ($2.74) EPS for the current fiscal year.

In other Invuity news, Director Eric W. Roberts sold 5,000 shares of the stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $13.47, for a total transaction of $67,350.00. Following the completion of the transaction, the director now owns 69,945 shares in the company, valued at approximately $942,159.15. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Eric W. Roberts sold 26,839 shares of the stock in a transaction dated Friday, September 2nd. The stock was sold at an average price of $14.00, for a total value of $375,746.00. Following the transaction, the director now owns 69,945 shares of the company’s stock, valued at approximately $979,230. The disclosure for this sale can be found here. Company insiders own 13.84% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in IVTY. Fiera Capital Corp purchased a new position in Invuity during the second quarter worth about $687,000. Paloma Partners Management Co purchased a new position in Invuity during the second quarter worth about $179,000. RTW Investments LLC boosted its position in Invuity by 6.2% in the second quarter. RTW Investments LLC now owns 226,042 shares of the company’s stock worth $2,154,000 after buying an additional 13,234 shares during the period. Coe Capital Management LLC purchased a new position in Invuity during the second quarter worth about $552,000. Finally, FMR LLC boosted its position in Invuity by 15.9% in the second quarter. FMR LLC now owns 2,009,300 shares of the company’s stock worth $19,149,000 after buying an additional 276,200 shares during the period. Hedge funds and other institutional investors own 48.42% of the company’s stock.

Invuity Company Profile

5 Day Chart for NASDAQ:IVTY

Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.